Regulatory Recap: AAM Looks To Confirmed HHS Secretary RFK Jr. To Fix ‘Broken System’

Also, News From Ukraine, Japan, China, Finland, France, And Italy

Generics Bulletin reviews the latest regulatory developments across the world.

Regulatory Recap
(Shutterstock)

“Making America healthy and keeping America healthy depends on access to affordable, reliable medicine,” said John Murphy III, president and CEO of the Association for Accessible Medicines, as the Department of Health and Human Services welcomed its confirmed leader Robert F. Kennedy Jr.

RFK Jr. has been a controversial pick for the HHS secretary role given his anti-vaccine rhetoric, which he has denied...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Generics Bulletin

Iron Sucrose Competition Expands With Viatris and Amphastar FDA Approvals

 
• By 

Viatris and Amphastar are expanding their complex generic portfolios with the planned launches of FDA-approved versions of Vifor Pharma/Daiichi Sankyo’s Venofer (iron sucrose). The FDA’s database also show Sandoz holds an approval for generic Venofer, though it has not disclosed launch plans.

Generic Drugs And AI: Maximum Daily Dose Tool Could Help US FDA Be ‘At The Forefront’

 

The FDA is testing a new artificial intelligence tool to help generic drug developers automate maximum daily dose calculations.

Amgen Welcomes Evolving Biosimilar Guidelines As Competitive Advantage

 
• By 

Amgen sees potential regulatory shifts toward streamlined biosimilar approvals as favorable, citing its strength in developing high-quality products.